Immunisations with the Pfizer-BioNTech vaccine, approved by the British medicines regulator, the MHRA, could start early next week for people in some high-priority groups, with 800,000 doses arriving in the UK in the first delivery.
Immunisations with the Pfizer-BioNTech vaccine, approved by the British medicines regulator, the MHRA, could start early next week for people in some high-priority groups, with 800,000 doses arriving in the UK in the first delivery.
This website uses cookies. By continuing to use this site, you accept our use of cookies.